Ad is loading...
MENU

CANF Can-Fite BioPharma Ltd Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers

Industry Biotechnology
CANF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
CANF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CANF is expected to report earnings to rise 767.00% to -8 cents per share on March 23

Can-Fite BioPharma Ltd CANF Stock Earnings Reports
Q4'22
Est.
$-0.09
Q3'22
Beat
by $0.08
Q2'22
Beat
by $0.04
Q1'22
Beat
by $0.14
The last earnings report on November 25 showed earnings per share of 0 cents, beating the estimate of -9 cents. With 60.69K shares outstanding, the current market capitalization sits at 13.20M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Ben Gurion Street
Phone
+972 39241114
Employees
5
Web
http://www.canfite.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
L83.670.87
+1.05%
Loews Corp
UAA9.940.09
+0.91%
Under Armour
OTRK1.73-0.05
-2.81%
Ontrak Inc
BLFS21.02-0.63
-2.91%
BioLife Solutions
RAIL9.90-0.49
-4.72%
FreightCar America

CANF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CANF has been loosely correlated with ALDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CANF jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
-1.51%
ALDX - CANF
46%
Loosely correlated
-1.41%
TPST - CANF
27%
Poorly correlated
-8.27%
ORMP - CANF
26%
Poorly correlated
-4.50%
ARWR - CANF
25%
Poorly correlated
-13.26%
VIR - CANF
25%
Poorly correlated
-7.29%
More